Group 1 - The report by CICC International Consulting highlights the extensive database and analytical capabilities of the company, which includes approximately 8 billion data resources across various sectors, ensuring authoritative and credible data support [2][24] - CICC has developed independent analytical models and consulting frameworks, collaborating with government, academia, and business sectors to enhance the quality and compliance of its consulting outcomes [2][24] Group 2 - Respiratory Syncytial Virus (RSV) is a highly contagious virus primarily affecting children under 5 and the elderly, with a seasonal prevalence from October to May, peaking in December to February in temperate regions [3][4] - The global burden of RSV is significant, with an estimated 33 million cases of lower respiratory tract infections in children under 5 annually, leading to 3.6 million hospitalizations and 118,000 deaths [4] Group 3 - The market for passive immunization agents against RSV in infants aged 0-1 in China is projected to grow at a compound annual growth rate (CAGR) of 78.40%, reaching a market size of 2.99 billion yuan from 2024 to 2028 [5][6] - The demand for RSV prevention products is expected to increase due to rising awareness and the introduction of various monoclonal antibody options, indicating a growing market potential [5][6]
2026-2032年0-1岁婴幼儿呼吸道合胞病毒预防被动免疫制剂行业发展现状与投资战略规划可行性报告-中金企信发布
Sou Hu Cai Jing·2026-02-03 02:42